Position in JNJ
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$11,490,617
+$77,714 QoQ
Shares Held
45,244
-3.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.95%
of 13F equity value
Holder Rank
#1,025
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ledyard National Bank holds $47,693,201 across 10 Drug Manufacturers - General names. JNJ ranks #1 (24.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
45,244 | $11,490,617 | |
| 2 | MRK |
Merck & Co., Inc.
|
71,938 | $9,244,033 | |
| 3 | AMGN |
Amgen Inc
|
25,394 | $9,195,674 | |
| 4 | LLY |
ELI LILLY & Co
|
4,276 | $5,128,762 | |
| 5 | PFE |
Pfizer Inc
|
181,271 | $4,365,005 | |
| 6 | ABBV |
AbbVie Inc.
|
17,080 | $4,298,010 | |
| 7 | GSK |
GSK plc
|
48,213 | $2,527,325 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
17,142 | $987,721 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,490,617 | 45,244 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $11,412,903 | 46,690 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $10,101,435 | 48,811 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $9,294,548 | 50,127 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $7,784,292 | 50,961 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $8,257,836 | 49,794 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $7,522,119 | 52,013 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $8,780,896 | 54,183 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $8,050,053 | 55,077 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $9,003,541 | 56,916 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $9,134,493 | 58,278 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $8,837,098 | 56,739 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $9,468,736 | 57,206 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $8,965,045 | 57,839 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $10,719,651 | 60,683 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $9,797,515 | 59,975 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $10,458,001 | 58,915 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $10,669,599 | 60,202 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $10,390,962 | 60,741 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $10,261,387 | 63,538 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $10,742,201 | 65,207 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $11,139,970 | 67,782 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $10,488,590 | 66,645 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $9,691,492 | 65,096 | Shares | Sole | 2020-10-21 | |
| 2020-06-30 | $8,942,942 | 63,592 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $7,926,283 | 60,446 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||